SCHEMBL5118767

SCHEMBL5118767

COC1Oc2c(c(=O)oc3cc(Cl)ccc23)C1c1c(O)c2ccc(Cl)cc2oc1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.37
NQO1 P15559 4/20 0.37
MAOB P27338 1/20 0.36
RXFP1 Q9HBX9 3/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MGAM O43451 3/20 0.35
MCL1 Q07820 1/20 0.34
TTR P02766 1/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5115207 0.89 NQO1 (0.47) NQO1MAOBRXFP1MAPTKDM4E
SCHEMBL6366185 0.88 NQO1 (0.45) HSD17B3NQO1RXFP1MAPTKDM4E
SCHEMBL5125455 0.88 TP53 (0.38) HSD17B3NQO1MAOBRXFP1TP53
SCHEMBL5125433 0.87 NQO1 (0.38) HSD17B3NQO1MAOBRXFP1MAPT
SCHEMBL5114488 0.84 NQO1 (0.38) NQO1RXFP1KDM4EALDH1A1HPGD
SCHEMBL5337846 0.83 NQO1 (0.39) HSD17B3NQO1RXFP1MGAMMCL1
SCHEMBL5118520 0.81 CSNK2A2 (0.38) HSD17B3NQO1MAOBRXFP1MAPT
SCHEMBL5117858 0.80 NQO1 (0.46) HSD17B3NQO1MAOBMAPTKDM4E
SCHEMBL5124909 0.80 NQO1 (0.37) NQO1MAOBRXFP1MAPTKDM4E
SCHEMBL5125229 0.79 PRNP (0.42) HSD17B3NQO1MAOBRXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S HSD17B3 153/4885NQO1 60/4885MAOB 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.